Recently, Advin COVID-19 Antigen Test @Home, a self-test for the SARS-CoV-2 antigen developed by Advin, a US-held subsidiary of Biotest, has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) after laboratory validation and clinical research evaluation showed that it met relevant standards.
About Biotest Biotech
Established in 2008, Hangzhou Biotest Biotech Co., Ltd. is a national high-tech enterprise which mainly develops and produces rapid diagnostic reagents. The company's leading products include infectious disease testing, drug abuse testing, tumor marker testing, cardiac marker testing and women health testing series, which are widely used in hospitals at all levels, CDC, blood stations, drug rehabilitation center and third-party testing institutions. Biotest Biotech focuses on independent research and development of products and technology accumulation, and has a highly innovative and pioneering R & D team, which provides company with a number of patented technologies and innovative products every year. Relying on strong R & D and technological innovation capabilities, Biotest is at the forefront in the research of colloidal gold, latex, fluorescence labeling technology, single/polyclonal antibody, gene recombinant antigen, synthetic antigen and other biological raw materials technology, as well as immunochromatography technology and other cutting-edge biological fields.
Please fill in your contact information
and your needs